OMIC

Singular Genomics Systems, Inc.

0.40 USD
+0.01 (+2.72%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Singular Genomics Systems, Inc. stock is up 0.92% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 May’s closed higher than April. 0% of analysts rate it a buy.

About Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology. The company manufactures G4 Instrument, a benchtop next generation sequencer, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument.